![List of the 150 largest Oncology Venture Capital Investors [Update 2024]](https://www.thousandinvestors.com/wp-content/uploads/2022/11/Thousand-Investors-Oncology.png)
This article directly stems from the research process for our global venture capital investors database. Based on this list and our advanced keyword crawler technology, we created a list of venture capital investors that mention oncology-related keywords on their website. The list – offered as an Excel file – is perfectly suited to get in touch with the most relevant investors in the field.
This article highlights three significant oncology venture capital investment funds in the United States from our keyword crawler generated oncology VC investor list.
1. Lightstone Ventures (Menlo Park)
Lightstone Ventures was founded in 2012 and has significant experience in the venture capital industry. They invest in early-stage businesses with a long-term partnership mindset. The company aims to invest in the medical sector, especially in biopharmaceuticals and medical technology. A company Lightstone Ventures is currently supporting is ALX Oncology. ALX Oncology are researching therapies that block special mechanisms, so that the immune system cannot be compromised by cancer cells.
2. Alta Partners (San Francisco)
Alta Partners, based in San Francisco, is a venture capital investor in the healthcare and life science sector. The company’s portfolio has produced over 70 FDA approved products. One of them is ChemGenex Pharmaceuticals, a biopharmaceutical company focused on oncology that develops small molecules with mechanisms to treat malignancies. Another interesting pharmaceutical company is Kiadis Pharma, who develops immunotherapies and adjunctive treatments for patients with stem cell transplants.
3. SV Health Investors (Boston)
SV Health Investors funds early- and late-stage projects in the life science and healthcare industry. They especially focus on Dementia, MedTech, public equities, and BioTech. A company that SV Health Investors has funded is Rondo Therapeutics. Rondo Therapeutics is a next-generation immune-oncology platform that treats solid tumours. Another portfolio company is Sitryx Therapeutics, who research cell metabolisms in order to develop disease modifying treatments in immune-oncology and immune-inflammation.
Picture Source: Fusion Medical Animation
